Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Neil Josephson, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- City of Hope
Duarte, California, United States
- Pmk Medical Group Inc., Dba Ventura County Hematology Oncology Specialists
Oxnard, California, United States
- Rocky Mountain Cancer Centers - Aurora
Aurora, Colorado, United States
- Mayo Clinic Cancer Center
Jacksonville, Florida, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Minnesota Oncology Hematology P.A.
Minneapolis, Minnesota, United States
- New York Oncology Hematology, P.C.
Albany, New York, United States
- University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Willamette Valley Cancer and Research / Usor
Eugene, Oregon, United States
- Northwest Cancer Specialists, P.C.
Tulatin, Oregon, United States
- St. Francis Hospital
Greenville, South Carolina, United States
- Texas Oncology - Bedford
Bedford, Texas, United States
- Texas Oncology - Dallas Presbyterian
Dallas, Texas, United States
- Texas Oncology - Medical City Dallas
Dallas, Texas, United States
- Texas Oncology Denton South
Denton, Texas, United States
- Texas Oncology - Fort Worth 12th Avenue
Fort Worth, Texas, United States
- Md Anderson Cancer Center / University of Texas
Houston, Texas, United States
- Md Anderson Cancer Center Leukemia Group
Houston, Texas, United States
- Texas Oncology - Central Austin Cancer Center
Round Rock, Texas, United States
- Cancer Centers of South Texas - Hoast
San Antonio, Texas, United States
- Texas Oncology - Waco
Waco, Texas, United States
- Oncology and Hematology Assoc of Sw Va Dba Blue Ridge Cancer Care
Blacksburg, Virginia, United States
- Virginia Cancer Specialists, Pc
Fairfax, Virginia, United States
- Puget Sound Cancer Centers
Edmonds, Washington, United States
- Cancer Care Northwest
Spokane Valley, Washington, United States
- Yakima Valley Memorial Hospital / North Star Lodge
Yakima, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2011
- Primary completion
- 31 Dec 2014
- Completion
- 31 Dec 2014
- Last update posted
- 4 Mar 2016
- Registered enrollment
- 84
- Registry id
- NCT01461538
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.